Singapore-based producer Barramundi Asia last week set out to raise SGD 40 million (€24.6 million/$29.1 million) in funds, and it plans to list on the stock exchange by the end of next year.
The group had a gear change in April when ex-Pharmaq CEO Andreas von Scholten took the reins after Joep Kleine Staarman retired.
